Production (Stage)
Burning Rock Biotech Limited
BNR
$3.64
$0.2557.53%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 03/31/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | 72.75M | 72.75M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | 72.75M | 72.75M |
| Cost of Revenue | -- | -- | -- | 23.81M | 23.81M |
| Gross Profit | -- | -- | -- | 48.95M | 48.95M |
| SG&A Expenses | -- | -- | -- | 89.03M | 89.03M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -- | -- | 157.37M | 157.37M |
| Operating Income | -- | -- | -- | -84.62M | -84.62M |
| Income Before Tax | -- | -- | -- | -81.99M | -81.99M |
| Income Tax Expenses | -- | -- | -- | 299.00K | 299.00K |
| Earnings from Continuing Operations | -- | -- | -- | -82.29 | -82.29 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -- | -- | -82.29M | -82.29M |
| EBIT | -- | -- | -- | -84.62M | -84.62M |
| EBITDA | -- | -- | -- | -67.02M | -67.02M |
| EPS Basic | -- | -- | -- | -80.34 | -80.34 |
| Normalized Basic EPS | -- | -- | -- | -5.00 | -5.00 |
| EPS Diluted | -- | -- | -- | -80.34 | -80.34 |
| Normalized Diluted EPS | -- | -- | -- | -5.00 | -5.00 |
| Average Basic Shares Outstanding | -- | -- | -- | 40.97M | 40.97M |
| Average Diluted Shares Outstanding | -- | -- | -- | 4.10M | 4.10M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |